Patent US6017977A successfully refreshed from Google Patents.
US6017977A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for embolizing blood vessels
Assignee: Micro Therapeutics Inc
•
Filing: 1997-06-04
•
Granted: 2000-01-25
•
Expires: 2017-06-04
Abstract
Abstract Disclosed are methods useful for treating vascular lesions wherein a non-particulate agent such as a metal coil is introduced into a vascular site (e.g., an aneurysm cavity) in conjunction with an embolizing composition comprising a biocompatible polymer and a biocompatible solvent. The biocompatible solvent is miscible or soluble in blood and also solubilizes the polymer during delivery. The biocompatible polymer is selected to be soluble in the biocompatible solvent but insoluble in blood. Upon contact with the blood, the biocompatible solvent dissipates from the embolic composition whereupon the biocompatible polymer precipitates. Precipitation of the polymer in the presence of the non-particulate agent permits the agent to act as a structural lattice for the growing polymer precipitate. In another embodiment, the biocompatible polymer composition can be replaced with a biocompatible prepolymer composition containing a biocompatible prepolymer.
Inventors
- 👤 Scott Evans
- 👤 II John Perl
- 👤 Richard Greff
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 07:09
CPC Classifications
A; A61; A61L; A61L24/00; A61L24/001; A61L24/0015; A61L24/02; A61L24/04; A61L31/00; A61L31/02; A61P; A61P13/00; A61P13/02; A61P15/00; A61P43/00; A61P9/00; A61P9/14; A61L2300/00; A61L2300/40; A61L2300/418; A61L2300/44; A61L2430/00; A61L2430/36
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
126 words
A kit of parts comprising: (a) a polymer composition comprising a biocompatible polymer, a biocompatible solvent which is selected from an organic material liquid at least at body temperature of a mammal in which the biocompatible polymer is soluble and a contrast agent which is capable of being monitored during injection into the mammal by radiography; and (b) a non-particulate agent or plurality of such agents wherein said agents are selected from the group consisting of metallic coils, coils with barbs, silk streamers, plastic brushes, detachable balloons, foam and nylon mesh wherein said polymer composition comprises a sufficient amount of said polymer such that, upon discharge into a vascular site, a solid mass precipitates in the presence of the non-particulate agent to embolize said vascular site.
Claim 2
Dependent Claim
126 words
A kit of parts comprising: (a) a polymer composition comprising a biocompatible polymer, a biocompatible solvent which is selected from an organic material liquid at least at body temperature of a mammal in which the biocompatible polymer is soluble and a contrast agent which is capable of being monitored during injection into the mammal by radiography; and (b) a non-particulate agent or plurality of such agents wherein said agents are selected from the group consisting of metallic coils, coils with barbs, silk streamers, plastic brushes, detachable balloons, foam and nylon mesh wherein said polymer composition comprises a sufficient amount of said polymer such that, upon discharge into a vascular site, a solid mass precipitates in the presence of the non-particulate agent to embolize said vascular site.
Claim 3
Dependent Claim
23 words
The kit of parts according to claim 1 wherein said biocompatible solvent is selected from the group consisting of dimethylsulfoxide, ethanol, and acetone.
Claim 4
Dependent Claim
14 words
The kit of parts according to claim 2 wherein said biocompatible solvent is DMSO.
Claim 5
Dependent Claim
18 words
The kit of parts according to claim 1 wherein said contrast agent is a water insoluble contrast agent.
Claim 6
Dependent Claim
28 words
The kit of parts according to claim 4 wherein said water insoluble contrast agent is selected from the group consisting of tantalum, tantalum oxide, tungsten and barium sulfate.
Claim 7
Dependent Claim
18 words
The kit of parts according to claim 1 wherein said contrast agent is a water soluble contrast agent.
Claim 8
Dependent Claim
16 words
The kit of parts according to claim 6 wherein said water soluble contrast agent is 2-((3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoyl)aminol)-2-deoxy-D-glucose.
Claim 9
Dependent Claim
22 words
The kit of parts according to claim 1 wherein said non-particulate agent is a metallic coil or a plurality of metallic coils.
Claim 10
Dependent Claim
16 words
The kit of parts according to claim 8 wherein said metallic coil is a platinum coil.
Claim 11
Dependent Claim
21 words
The kit of parts according to claim 1 wherein the kit further comprises a catheter capable of delivering said polymer composition.
Claim 12
Dependent Claim
25 words
The kit of parts according to claim 10 wherein the catheter capable of delivering said polymer composition is also capable of delivering said non-particulate agent.
Claim 13
Dependent Claim
19 words
The kit of parts according to claim 10 which further comprises a catheter capable of delivering said non-particulate agent.
References Cited (Backward Citations)
US4177267A
Cited
US3527224A
Cited
US3591676A
Cited
US3711606A
Cited
US3711602A
Cited
US4563184A
Cited
US4725271A
Cited
US4747845A
Cited
US4902728A
Cited
US5340849A
Cited
US5278202A
Cited
US5278201A
Cited
US4938763B1
Cited
US4938763A
Cited
US4997643A
Cited
US5077049A
Cited
US5324519A
Cited
US5368859A
Cited
US5420176A
Cited
JPH0557014A
Cited
JPH05253283A
Cited
JPH06107549A
Cited
US5718711A
Cited
US5580568A
Cited
US5762909A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-01-24 | 2003-07-26 | 2004-01-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-01-24 | 2007-07-26 | 2008-01-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-01-24 | 2011-07-26 | 2012-01-25 | $7700.00 | Window Closed / Lapsed |